44 results
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
, or its employees (or Persons it currently intends to hire) made prior to their employment by the Company, except for technology that is licensed
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
and avoid third-party patent interference or patent infringement claims; and
attract, hire and retain qualified personnel.
In addition, because … an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
property rights and avoid third-party patent interference or patent infringement claims; and
attract, hire and retain qualified personnel.
In addition … do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience
8-K
EX-10.1
fr442
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
424B5
ac2nyr
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
sk3dc3f0 n6obzfwizm
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
hqg8x0
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
la6ceilvp un
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
2um4j
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
kd5utibhylx7w 0r
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
wgm6in
12 Apr 19
Prospectus supplement
4:41pm